Unigene in-licenses potential therapies from University of London
These rights were acquired from Queen Mary, University of London. The conditions targeted by the inventions include osteoarthritis, rheumatoid arthritis, inflammatory bowel disease, and cardiac reperfusion (restoration of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.